Stay updated on Pembrolizumab in Untreated B-Cell NHL Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Untreated B-Cell NHL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Untreated B-Cell NHL Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page’s footer revision/version has been updated from v3.5.2 to v3.5.3 for the ClinicalTrials.gov site software.
    Difference
    0.1%
    Check dated 2026-04-23T21:54:11.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Updated the site's release label from Revision: v3.5.0 to Revision: v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T12:26:59.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    Added: Revision v3.5.0; Removed: Revision v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T21:25:09.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T20:11:46.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added. The government funding lapse notice and the older Revision: v3.4.1 entry were removed.
    Difference
    0.4%
    Check dated 2026-02-11T05:35:10.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    A new site-wide notice about government funding status was added and the page revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T05:15:31.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Untreated B-Cell NHL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Untreated B-Cell NHL Clinical Trial page.